AI assistant
Streamex Corp. — Director's Dealing 2015
Jul 20, 2015
35540_dirs_2015-07-20_a473d756-5747-4ce2-9450-c1904e9abe22.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2015-07-20
Reporting Person: Holzer Asher (Director, Chief Scientific Advisor)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.001 par value per share | 90000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options to Purchase Common Stock | $2.00 | 2019-09-21 | Common Stock (243000) | Direct | |
| Options to Purchase Common Stock | $2.50 | 2021-09-01 | Common Stock (75000) | Direct | |
| Options to Purchase Common Stock | $2.53 | 2025-06-22 | Common Stock (25000) | Direct |
Footnotes
F1: The options vested 81,000 on September 21, 2013, the first anniversary of the grant, and 81,000 on September 21, 2014, the second anniversary of the grant. The remaining 81,000 will vest on September 21, 2015, the third anniversary of the grant. As of the date of this report, the options are vested and exercisable as to 162,000 underlying shares.
F2: The options vest in 12 consecutive monthly installments beginning one month from June 22, 2015, the date of the grant. As of the date of this report, the options are vested and exercisable as to zero underlying shares.